Ten63 Therapeutics: Funding, Investors & Team (Nov 2026)
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the most lethal diseases. It combines low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates. The company's platform, COPPER, leverages its proprietary AI and state-of-the-art physical models to explore an unprecedentedly large chemical space, allowing them to discover new therapeutics to targets previously believed undruggable.
Ten63 Therapeutics has raised $15.9M across 2 funding rounds on record, the most recent an undisclosed round announced in Feb 2026.
Ten63 Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Ten63 Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Ten63 Therapeutics raised $15.9M in a Series A announced in May 2023.
2.8 years later, an undisclosed round was announced in Feb 2026 with no disclosed amount.
Ten63 Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Ten63 Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like Ten63 Therapeutics in Biotechnology and Durham
Companies Similar to Ten63 Therapeutics
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…
Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Ten63 Therapeutics Funding FAQs
What does Ten63 Therapeutics do?
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the most lethal diseases. It combines low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates. The company's platform, COPPER, leverages its proprietary AI and state-of-the-art physical models to explore an unprecedentedly large chemical space, allowing them to discover new therapeutics to targets previously believed undruggable.
How much funding has Ten63 Therapeutics raised?
Ten63 Therapeutics has raised $15.9M across 2 rounds on record.
When did Ten63 Therapeutics last raise funding?
Ten63 Therapeutics' most recent funding round on record was announced in Feb 2026. The amount was not disclosed.
Who is the CEO of Ten63 Therapeutics?
Marcel Frenkel is listed as CEO at Ten63 Therapeutics.
Where is Ten63 Therapeutics headquartered?
Ten63 Therapeutics is based in Durham, North Carolina, United States.
How many employees does Ten63 Therapeutics have?
Ten63 Therapeutics is in the 11-50 employee band.
About FundedIQ's Ten63 Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ten63 Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.